Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Negative symptoms are a core aspect of psychopathology in schizophrenia. Currently available pharmacological agents have proven minimally efficacious for remediating negative symptoms. A promising treatment avenue is the intranasal administration of the neuropeptide oxytocin. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabe, Michel, Zhao, Nan, Crippa, Alessio, Strauss, Gregory P, Kaiser, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378078/
https://www.ncbi.nlm.nih.gov/pubmed/33890987
http://dx.doi.org/10.1093/ijnp/pyab020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378078/
https://www.ncbi.nlm.nih.gov/pubmed/33890987
http://dx.doi.org/10.1093/ijnp/pyab020

Ejemplares similares